Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-04-25 16:18 |
Purple Biotech’s Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as La…
|
English | 36.7 KB | ||
| 2024-03-31 01:53 |
FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
|
English | 1.3 MB | ||
| 2024-03-31 01:53 |
FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
|
English | 35.9 KB | ||
| 2024-03-28 14:17 |
to Present New Data On its Oncology Drug NT219 at AACR 2024
|
English | 176.6 KB | ||
| 2024-03-28 14:17 |
to Present New Data On its Oncology Drug NT219 at AACR 2024
|
English | 36.6 KB | ||
| 2024-03-14 14:48 |
Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Te…
|
English | 170.0 KB | ||
| 2024-03-14 14:48 |
Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Te…
|
English | 36.6 KB | ||
| 2024-03-07 00:31 |
Corporate Presentation March 2024
|
English | 12.6 MB | ||
| 2024-03-07 00:31 |
Corporate Presentation March 2024
|
English | 36.6 KB | ||
| 2024-03-06 00:10 |
FORM 20F FOR 2023
|
English | 1.6 MB | ||
| 2024-03-06 00:10 |
FORM 20F FOR 2023
|
English | 36.8 KB | ||
| 2024-03-05 16:10 |
6K:Fourth Quarter and Full-Year 2023 Financial Results
|
English | 213.0 KB | ||
| 2024-03-05 16:10 |
6K:Fourth Quarter and Full-Year 2023 Financial Results
|
English | 36.8 KB | ||
| 2024-02-27 21:15 |
Purple Biotech Presents Data of its Phase 1 Head & Neck Cancer of NT219 in comb…
|
English | 194.8 KB | ||
| 2024-02-27 21:15 |
Purple Biotech Presents Data of its Phase 1 Head & Neck Cancer of NT219 in comb…
|
English | 36.8 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
